Chung Wu Investment Group »

Vir Biotechnology shares owned by Chung Wu Investment Group

Quarter-by-quarter ownership of Vir Biotechnology (VIR) shares owned by Chung Wu Investment Group from 13F filings

Historical chart of Chung Wu Investment Group investment in Vir Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Vir Biotechnology held by Chung Wu Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vir Biotechnology by Chung Wu Investment Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $31k 3.4k 8.96

More positions owned by Chung Wu Investment Group

Ishares Tr Core S&p500 Etf Core S&p500 Etf (IVV)
Neos S&p 500 High Income Etf Neos S&p 500 Hi (SPYI)
State Street Spdr Dow Jones Industrial Average Etf Ut Ser 1 (DIA)
Neos Nasdaq 100 High Income Etf Nasdaq 100 High (QQQI)
Microsoft Corporation (MSFT)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
Micron Technology (MU)
Eaton Vance Enhanced Equity Incm. Fd. II (EOS)
NVIDIA Corporation (NVDA)
Antero Midstream Corp antero midstream (AM)
Exxon Mobil Corporation (XOM)
State Street Spdr S&p 500 Etf Trust Tr Unit (SPY)
MasTec (MTZ)
Ge Vernova (GEV)

View all positions for Chung Wu Investment Group

Top funds holding Vir Biotechnology

BlackRock
Arch Venture Corp
Vanguard Group
Sb Investment Advisers
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
Goldman Sachs Group
FMR
Morgan Stanley
ADAR1 Capital Management
Geode Capital Management
Dimensional Fund Advisors
Citadel Advisors
Soleus Capital Management

View all funds holding Vir Biotechnology